Samantha Surrey

Samantha is the founder of Surrey Capital Partners (SCP), a life science impact innovation fund. Prior to Surrey Capital Partners, Samantha Co-Founded Decision Medical Ventures, a life sciences investment firm focused on bringing to market advanced medical ultrasound technology. Samantha’s prior experience includes Worldwide Business Development and M&A Deal Finance at GSK, where she was responsible for managing a portfolio of direct investments and fund of funds, negotiating global licensing deals, joint ventures, and acquisitions with other pharmaceutical and biotech companies. Prior to GSK, Samantha worked at Bioscience Managers in London, focusing on life sciences in areas of biotechnology, medical devices, therapeutics, and nanotechnology. She also worked at the UK Cabinet Office in the Ministry of Science and Technology.

Samantha serves on the Boards of Directors of DSMC, AiM Medical Robotics and Outlook Surgical Endoscopy System. Samantha also serves on the advisory boards of Endeavor Healthcare, AZ Therapies as well as the Board of Advisors for University of Pennsylvania School for Engineering, Cornell University Center for Entrepreneurship, Society for Brain Mapping and Therapeutics and Google Accelerator with a special focus on A.I. for Healthcare.

Samantha graduated summa cum laude with an M.S. Eng. in biomedical engineering from the University of Pennsylvania, with a joint published thesis in robotic surgery with the Engineering School at Oxford University. She holds an undergraduate degree in Engineering and Applied Mathematics from Cornell University and is also a Harvard Business School alumna, Owner’s President Management Program (OPM 53).